- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02015195
Effective Treatments for Jellyfish Stings
Efficacy of Topical Agents in the Treatment of Chrysaora Chinensis Stings
The purpose of the study is to attempt to determine which treatment from commonly used treatments is the best at reducing pain and redness of the skin after a sting from a Portuguese Man of War, Chrysaora chinensis, or Chrysaora fuscescens.
Jellyfish stings are a common occurrence in many parts of the world causing significant morbidity to persons stung by jellyfish while participating in marine activities whether commercial or recreational. Much debate and confusion exist both in the medical literature and the common recommendations regarding how to treat persons stung by jellyfish. Specifically concerning what topical treatments are most efficacious at decreasing envenomation by nematocyst on skin, preventing the firing of un-discharged nematocyst, decreasing inflammation and pain resulting from envenomation by nematocyst. Antidotal recommendations and past studies have referenced numerous different topical treatments for jellyfish stings including but not limited to vinegar, urine, alcohol, distilled spirits, ammonia, bleach, acetone, bicarbonate slurry, lidocaine, meat tenderizer, Coca Cola, old wine, salt water, cold packs, hot water, and commercial products such as Stingose and Stingaid. Conflicting data exists regarding what works and what does not for nematocysts discharge, skin erythema, and pain reaction.
The investigators would like to investigate which treatment is best out of some of the more commonly studied treatments for reducing pain and erythema.
The investigators would like to complete a research study to try to bring some reasonable evidence to the field treatment of jellyfish stings, namely, the decontamination process (e.g., what can you put on a jellyfish sting that will be helpful, based on real data?).
The questions asked are as follows:
- What topical treatments for jellyfish stings actually decrease the amount of inflammation seen on a macroscopic level on the skin of humans?
- What topical treatments for jellyfish stings actually decrease the sensation of pain in humans?
- Do topical chemical treatments cause different outcomes when exposed to the above parameters?
- Do different species of jellyfish nematocysts react differently based on the type of topical chemical treatment used? What is the variation of effects of topical treatments based on the species of jellyfish sting?
Specifically, the investigators will be stinging human subject on both arms with a segment of tentacle for approximately 2 minutes. This will be followed by no treatment on one arm (control arm) and by treatment on the other arm with either: acetic acid (5%), sodium bicarbonate slurry (50%), papain slurry (70%), ammonia (10%), viscous lidocaine (4%), isopropyl alcohol (70%), or hot tap water (40 degrees Celsius). Outcomes measured will include pain and erythema.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Palo Alto, California, United States, 90035
- Stanford University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages 18-65 years
- Healthy volunteers
Exclusion Criteria:
- Known history of allergic reaction or anaphylaxis to prior Cnidaria sting of there envenomations
- Family history of anaphylaxis to any sting from either Cnidaria, bee, or wasp
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acetic Acid 5%
Acetic Acid (5%) Dosage form: Liquid Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes
|
Other Names:
Other Names:
|
|
Experimental: Sodium Bicarbonate Slurry (50%)
Sodium Bicarbonate Slurry (50%) Dosage form: Liquid slurry Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes
|
Other Names:
|
|
Experimental: Papain Slurry (70%)
Papain Slurry (70%) Dosage form: Liquid slurry Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes
|
Other Names:
Other Names:
|
|
Experimental: Household ammonia (10%)
Ammonia (10%) Dosage form: Liquid Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes
|
Other Names:
Other Names:
|
|
Experimental: Lidocaine (4%)
Lidocaine (4%) Dosage form: Liquid Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes
|
Other Names:
Other Names:
|
|
Experimental: Isopropyl Alcohol (70%)
Isopropyl Alcohol (70%) Dosage form: Liquid Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes
|
Other Names:
Other Names:
|
|
Experimental: Hot Water (40 degrees Celsius)
Hot Tap Water (40 degrees Celsius) Dosage form: Liquid Dosage: 5 ml topical Frequency: every 2 minutes Duration: 30 minutes
|
Other Names:
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Change in Pain in the Treated Human Arm (Not Placebo) From Baseline Determined by Measures (17) Taken Over 24 Hours
Time Frame: 24 hours
|
Pain is measured on a scale of 1-10 with 0 being no pain and 10 being worse pain ever felt.
Baseline pain will be measured immediately after being stung for 2 minutes without any treatment.
Subsequent pain felt at every 2 minutes for 30 minutes, at 1 hour post sting, and at 24 hours post sting will be based on changes from the original baseline pain.
Mean change is defined as the mean change in pain from all time points measured from each participant and then averaged for each group.
The control arm (placebo) was collected and analyzed in parallel to the treatment arm.
The "mean change" for the treatment arm was then compared with the "mean change" for the control arm as a baseline.
Hence, the data presented are the estimated effect for each treatment group compared to the control arms for each group.
|
24 hours
|
|
Mean Change in Erythema (Redness) in the Treated Human Arm (Not Placebo) From Baseline Determined by Measures (3) Taken Over 24 Hours
Time Frame: 30 minutes, 1 hour, and 24 hours
|
Visual inspection of sting sites will be done at 30 minutes post sting (after treatment completed), 1 hour post sting, and 24 hours post sting.
Erythema Index (EI) imeasures increase in cutaneous vasodilation.
A computer-measured (Image-J software) EI was used to remove subjectivity.
A numeric score was created for the level of erythema, with "0" representing baseline erythema on the control arm.
Any positive number indicates more and negative number less erythema on treatment arm compared to placebo.
EI values were measured on a "scale" from -20 to +20 with "0" being the midpoint where there would be equal amounts of erythema on both the treatment and control arm.
The erythema they experienced on the "treatment arm" was then measured as more erythema (a positive value up to 20) or less erythema (a negative value up to -20).
|
30 minutes, 1 hour, and 24 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Paul S Auerbach, MD, Division of Emergency Medicine, Stanford University Medical Center
- Study Director: Matthieu P DeClerck, MD, Division of Emergency Medicine, Stanford University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Chemically-Induced Disorders
- Wounds and Injuries
- Poisoning
- Bites and Stings
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Anti-Infective Agents, Local
- Anti-Infective Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Antineoplastic Agents
- Immunologic Factors
- Protective Agents
- Anti-Bacterial Agents
- Membrane Transport Modulators
- Adjuvants, Immunologic
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Anticarcinogenic Agents
- Ethanol
- Lidocaine
- Acetic Acid
- Retinol acetate
Other Study ID Numbers
- jsp-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Jellyfish Stings
-
Mahidol UniversityCompletedJellyfish Dermatitis | Jellyfish VenomsThailand
-
London School of Hygiene and Tropical MedicineUnknownInsect Bites | StingsUnited Kingdom
-
University of GuadalajaraCompleted
-
Laboratorios de Biologicos y Reactivos de México...Completed
-
Laboratorios de Biologicos y Reactivos de México...Completed
-
C.R.Darnall Army Medical CenterCompletedInsect Bites and Stings
-
Assiut UniversityNot yet recruiting
-
Mantecorp Industria Quimica e Farmaceutica Ltd.Unknown
-
Mantecorp Industria Quimica e Farmaceutica Ltd.Unknown
-
Assiut UniversityNot yet recruiting
Clinical Trials on No treatment
-
HealthpointCompletedVenous Leg Ulcer (VLU)Germany, Poland, Belgium, Hungary, Czechia
-
HealthpointCompleted
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
University Hospital, GrenobleUnknownObstructive Sleep Apnea Syndrome | HypertensionFrance
-
Anna Alessandri BonettiCompletedPain | Sleep Apnea Syndromes | Sleep Apnea, Obstructive | Sleep Apnea | Temporomandibular Disorder | Pain, FaceItaly
-
Surf TherapeuticsRecruitingRheumatoid Arthritis (RAUnited States
-
Ottawa Heart Institute Research CorporationActive, not recruitingMitral RegurgitationCanada
-
University of PaviaCompletedClinical Efficacy of Biomimetic Hydroxyapatite in the Treatment of Molar Incisor Hypomineralization.Molar Incisor HypomineralizationItaly
-
Institute of Liver and Biliary Sciences, IndiaRecruitingChronic Liver Disease and CirrhosisIndia
-
Institute of Liver and Biliary Sciences, IndiaRecruitingBile Duct Diseases | Pancreas Disease | Hepatobiliary DiseaseIndia